ResMed

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ResMed and other ETFs, options, and stocks.

About RMD

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases.

CEO

Michael J. Farrell

CEOMichael J. Farrell

Employees

10,600

Employees10,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1989

Founded1989

Employees

10,600

Employees10,600

RMD Key Statistics

Market cap

28.87B

Market cap28.87B

Price-Earnings ratio

19.55

Price-Earnings ratio19.55

Dividend yield

1.18%

Dividend yield1.18%

Average volume

1.73M

Average volume1.73M

High today

$203.04

High today$203.04

Low today

$198.22

Low today$198.22

Open price

$201.22

Open price$201.22

Volume

1.27M

Volume1.27M

52 Week high

$293.81

52 Week high$293.81

52 Week low

$180.27

52 Week low$180.27

Stock Snapshot

As of today, ResMed(RMD) shares are valued at $198.99. The company's market cap stands at 28.87B, with a P/E ratio of 19.55 and a dividend yield of 1.18%.

During the trading session on 2026-07-19, ResMed(RMD) shares reached a daily high of $203.04 and a low of $198.22. At a current price of $198.99, the stock is +0.4% higher than the low and still -2.0% under the high.

Trading activity shows a volume of 1.27M, compared to an average daily volume of 1.73M.

Over the past 52 weeks, ResMed(RMD) stock has traded between a high of $293.81 and a low of $180.27.

RMD News

Simply Wall St 1d

How Investors Are Reacting To ResMed Downgrade Amid FY27 Cost and Supply Pressures

RBC Capital recently downgraded ResMed to Sector Perform from Outperform, pointing to FY27 pressures from Astral ventilator replacements, higher input costs, an...

TipRanks 3d

ResMed downgraded to Sector Perform from Outperform at RBC Capital

RBC Capital downgraded ResMed (RMD) to Sector Perform from Outperform with a price target of $234, down from $276. ResMed faces a number of challenges in FY27,...

TipRanks 5d

Resmed Maintained at Hold as Astral Ventilator Safety Notice Clouds Outlook; $230 Price Target Unchanged

Morgan Stanley analyst David Bailey maintained a Hold rating on Resmed yesterday and set a price target of $230.00. TipRanks has entered a new arena in the inv...

Analyst ratings

63%

of 30 ratings

Buy

63.3%

Hold

30%

Sell

6.7%

People also own

Based on the portfolios of people who own RMD. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.